Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.
Oncologist
; 22(4): 480-483, 2017 04.
Article
in En
| MEDLINE
| ID: mdl-28242791
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Down Syndrome
/
Cell Cycle Proteins
/
Receptor, Fibroblast Growth Factor, Type 1
/
Leukemoid Reaction
/
Neoplasms
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom